IHUB post for today. It should be ok as there has only been

New Post Public Reply Private Reply Replies (0) Message Board
martymech
243
IHUB post for today. It should be ok as there has only been one post deleted since seaside2 got the ol boot. What a nice change. Anyway here's the post in case it gets deleted. It's a pretty short post. lol I was half asleep when I put it together so if it sounds as though I was repeating myself I was probably repeating myself I was probably repeating myself. lol that one was on purpose. Besides there are a couple of guys over there that can benefit from some of the key topics being repeated several times so I just let the rough draft fly in it's not so much edited version.
============================================



martymech
Member Level

Friday, February 25, 2022 2:31:53 AM

Re: None
Post# of 54584
$$$EGOC$$$ Interesting things going wouldn't you all agree?

I read a lot of the comments concerning that Notice of Material Event that was put out by EGOC yesterday. I have to say some pleasant and some not so pleasant. Some have nothing to do with what is going on like saying the chinese government is blocking EGOC or everything that we were told has been wrong. I kind of had to sit back a bit and wonder if some here are even talking about the same EGOC stock and if they even read my opinions over the course of the last month or so. I don't sit on the board of directors of EGOC so I don't have a say in how or what they do but I do have my own opinions of what I think is going to happen. That's all they are. My opinions. I try to make that clear in every post. I don't think my opinions have been wrong but everyone is entitled to their own opinions for sure!

I "believe" that EGOC acted appropriately by withdrawing their application, my only complaint is they should have done it sooner. I said this in previous posts about 2 to 3 weeks back. The delays going on at FINRA are insane. In this latest "Notice Of Material Event" they mentioned two deciding factors. One was addressing the long delays and the other had something to do with some preferred shares not being returned to the transfer agent when someone was ordered to do so. Paraphrasing of course. Now then I could see that they would be able to remedy this hurdle by going through the Florida Courts and filing some sort of request for the courts to force the hand of said persons failure to deliver on a court ordered process and that would take time, heck it could take months as back logged as the system is these days but it would get done and if it couldn't get done then the court would issue it's reasons why that would be impossible and FINRA would be content with the legal process and allow the name change and ticker change to occur. BAM. So in my OPINION when EGOC says in their notice yesterday that they are moving forward with the original ticker and name and moving forward with their company plans this is big and great news. They are not throwing in the towel. If they were they wouldn't have bothered with that notice yesterday. I believe they will move forward with the roll out and they will quietly work on overcoming that hick up or hurdle now that they know exactly what needs to happen to get the new name and ticker changed. It's not a crisis, the sky is not falling, no reason to self implode or explode it's just a hick up along the road. I believe EGOC will have a board meeting if they haven't already and vote on the precise course of action as I don't think they want to operate under the EGOC name and ticker and they are determined to have the Yicheng Name proudly out in front. It will get done in my opinion but not as fast as they or we would like it to happen. These things happen and it seems to have been something out of the control of the new company. Heck they may even vote on a new registration approach where they get the new name and ticker along with becoming an SEC filing company.

The "moving forward" part as stated in the filing is just that. They are moving forward with the company plans. I expect press releases, filings, information "TO THE MAX" (anyone remember that line?) to be headed our way. Just my opinions but really folks there isn't anything in these events that bother me in the least. Well, that's not entirely true. I would say that I was a bit bothered by some persons reactions.. some were ,,, well,,, a bit silly.

So stay tuned, don't freak out, take your meds or what ever gets you through the day, don't have a total nervous breakdown, don't blame the chinese government for somehow blocking... (that one really cracked me up) it's all good as EGOC is getting ready to roll out the goods and for at least a while we wont be seeing the much desired Yicheng name attached to our new company but it will happen eventually! Mark my words or rather mark my opinions!Breathe in Breathe out breathe in Breathe out.. JMO Oh I should also mention that I am looking at buying a bunch more shares if anyone wants to sell. Let me know when you have totally snapped and are off your meds so I can be first in line for dem cheapies. Have a good one! Don't forget this is my only post today!

Energy 1 Corporation (EGOC) Stock Research Links

EGOC Board Company Profile Buy Rating Time & Sales News Filings Financials
What I post is my opinions and thoughts based on my research. Please do your own DD before buying or selling any stock. I am just as capable as the next guy in making good or bad investment choices! We win a few, we lose a few. That is the nature of the game!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 79

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 421

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 72

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 140

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 93

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 312

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 87

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Nippon Express Europe Partners with Formag for Logistics Support

Updated Category News Views 213

Nippon Express Europe and Formag Form New Logistics Partnership Nippon Express Europe GmbH, part of NIPPON EXPRESS HOLDINGS, INC., has recently signed a cooperation agreement with Ukrainian logistics provider, Formag-Kiev. This significant collaboration aims to provide essential logistical support for the reconstruction of Ukraine. Commitment to Ukrainian Reconstruction...

Continue Reading
Escalating Legal Action Over LIBRA Token Sparks Controversy

Updated Category News Views 265

Legal Developments in the LIBRA Token Case A prominent Argentine lawyer has made headlines by calling for global law enforcement to apprehend a cryptocurrency figure involved in the LIBRA token controversy. Details of the Extradition Request Gregorio Dalbon, known for his defense work with former Argentine President Cristina Fernandez in a prominent corruption matter, has...

Continue Reading
Tesla Prevails in Motion to Dismiss Racial Bias Lawsuit

Updated Category News Views 230

Tesla's Legal Victory Against Racial Bias Allegations Under the direction of Elon Musk, Tesla Inc. (NASDAQ: TSLA) has successfully overturned a significant class action lawsuit that was brought forth by more than 6,000 African American workers. These workers alleged racial discrimination at Tesla's Fremont assembly plant. This ruling is a key moment in the ongoing...

Continue Reading
ZenaTech Unveils Specialized AI Hub to Bolster US Defense Tactics

Updated Category News Views 100

ZenaTech Launches Innovative AI Development Center Vancouver, British Columbia – ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) has taken a significant stride toward advancing artificial intelligence technologies by establishing Zena AI, Inc. This new AI Development Center will focus on crafting specialized AI solutions tailored for defense and homeland security...

Continue Reading
Investors Reminded of Action Timeline Against ICON plc - ICLR

Updated Category News Views 172

Understanding the Legal Proceedings Against ICON plc In an important reminder for shareholders, Kahn Swick & Foti, LLC is emphasizing the critical timeline for investors affected by losses from their holdings in ICON plc (NASDAQ: ICLR). The firm, led by former Louisiana Attorney General Charles C. Foti, Jr., is urging investors who incurred losses exceeding $100,000 to...

Continue Reading